We just received data on a new analyst forecast for $MAR. Richard Clarke from Bernstein set a price target of 369.0 for MAR.
To track analyst ratings and price targets for $MAR, check out Quiver Quantitative's $MAR forecast page.
Should you buy $MAR?
Some analysts are better than others. To view the past performance of Bernstein, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$MAR Price Targets
Multiple analysts have issued price targets for $MAR recently. We have seen 8 analysts offer price targets for $MAR in the last 6 months, with a median target of $290.5.
Here are some recent targets:
- Richard Clarke from Bernstein set a target price of $369.0 on 01/06/2026
- Brandt Montour from Barclays set a target price of $276.0 on 12/17/2025
- Lizzie Dove from Goldman Sachs set a target price of $345.0 on 12/15/2025
- Patrick Scholes from Truist Securities set a target price of $283.0 on 12/04/2025
- Trey Bowers from Wells Fargo set a target price of $329.0 on 11/18/2025
- Ari Klein from BMO Capital set a target price of $285.0 on 11/05/2025
- Stephen Grambling from Morgan Stanley set a target price of $296.0 on 10/22/2025
$MAR Insider Trading Activity
$MAR insiders have traded $MAR stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $MAR stock by insiders over the last 6 months:
- DEBORAH MARRIOTT HARRISON sold 70,000 shares for an estimated $20,414,100
- WILLIAM P BROWN (Group Pres., US and Canada) sold 6,666 shares for an estimated $1,866,719
- RENA HOZORE REISS (EVP & General Counsel) has made 0 purchases and 2 sales selling 5,483 shares for an estimated $1,574,224.
- FELITIA LEE (Controller and CAO) has made 0 purchases and 4 sales selling 2,490 shares for an estimated $758,049.
- PEGGY ROE (EVP & Chf. Customer Officer) sold 2,000 shares for an estimated $584,240
- BENJAMIN T. BRELAND (CHRO & EVP, Global Ops. Serv.) sold 1,650 shares for an estimated $472,065
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MAR Revenue
$MAR had revenues of $6.5B in Q3 2025. This is an increase of 3.74% from the same period in the prior year.
You can track MAR financials on Quiver Quantitative's MAR stock page.
$MAR Congressional Stock Trading
Members of Congress have traded $MAR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MAR stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$MAR Hedge Fund Activity
We have seen 599 institutional investors add shares of $MAR stock to their portfolio, and 595 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JPMORGAN CHASE & CO removed 2,813,231 shares (-29.7%) from their portfolio in Q3 2025, for an estimated $732,677,881
- WELLINGTON MANAGEMENT GROUP LLP added 1,637,119 shares (+21.7%) to their portfolio in Q3 2025, for an estimated $426,371,272
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 973,918 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $253,647,203
- PRICE T ROWE ASSOCIATES INC /MD/ removed 798,918 shares (-32.5%) from their portfolio in Q3 2025, for an estimated $208,070,203
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 712,072 shares (+56.2%) to their portfolio in Q3 2025, for an estimated $185,452,031
- CITADEL ADVISORS LLC added 655,933 shares (+52.1%) to their portfolio in Q3 2025, for an estimated $170,831,190
- UBS GROUP AG added 372,364 shares (+39.6%) to their portfolio in Q3 2025, for an estimated $96,978,480
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
